版本:
中国

BRIEF-Quest Pharmatech says positive interim results from mid-stage clinical study of Oregovomab

Nov 29 Quest Pharmatech Inc

* Quest Pharmatech says positive interim results from phase 2b clinical study of Oregovomab

* Quest Pharmatech Inc- Oregovomab in combination with chemotherapy improves clinical outcome in ovarian cancer patients Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐